MDR inhibitors (Procter & Gamble)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameMDR inhibitors (Procter & Gamble)
Drug Alias Namemultidrug resistance inhibitors (Procter & Gamble)PGE-2799041PGE-3470383
ClassificationSmall molecules
Mechanisms of ActionAnticancer multidrug resistance inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProcter & Gamble Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProcter & Gamble Company
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A